Ingevity (NGVT) Cost of Revenue (2015 - 2026)

Ingevity (NGVT) has 12 years of Cost of Revenue data on file, last reported at $141.6 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $141.6 million, up 4.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $735.3 million (down 4.38% YoY), and the FY2025 annual result was $706.1 million, down 3.97% from the prior year.
• Cost of Revenue declined to $141.6 million in Q1 2026 per NGVT's latest filing, from $167.3 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $328.8 million in Q2 2023 and troughed at -$137.5 million in Q4 2023.
• A 5-year average of $212.6 million and a median of $240.4 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue tumbled 149.42% in 2023, then surged 218.84% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $278.2 million in 2022, then plunged by 149.42% to -$137.5 million in 2023, then surged by 218.84% to $163.4 million in 2024, then grew by 2.39% to $167.3 million in 2025, then slipped by 15.36% to $141.6 million in 2026.
• Business Quant data shows NGVT's Cost of Revenue at $141.6 million in Q1 2026, $167.3 million in Q4 2025, and $199.2 million in Q3 2025.